Name
Investigator-Initiated Trials (IIT) Breakout: Pros and Cons of IIT Program Structures - Which One Is Right for Your Organization?
Date & Time
Monday, October 17, 2022, 2:45 PM - 3:30 PM
Location Name
Wilshire AB
Description
Description: The structure of an investigator-initiated trial (ITT) program can take many forms depending on the policies of the researcher’s institution and the involvement of the company whose investigational product is being studied. For some IITs, the researcher’s institution may act as the sponsor, while for others the researcher acts as the sponsor, and in some IITs (but not all) the researcher and company work closely together to develop the IIT protocol and throughout the conduct of the IIT. This session aims to discuss varying IIT program structures and the potential challenges and other considerations to consider in designing an IIT program that can best meet the desired research goals.
Speakers
Sarah Wicks - Associate - Goodwin Procter
Sierra Clark - Industry Contracts Manager - University of California San Francisco
Lin Feng - Clinical Research Coordinator - UBMD Orthopaedics & Sports Medicine
Matthew Porteus - Professor - Stanford University
Julie Tibbets - FDA Practice Chair - Goodwin Procter LLP
Sierra Clark - Industry Contracts Manager - University of California San Francisco
Lin Feng - Clinical Research Coordinator - UBMD Orthopaedics & Sports Medicine
Matthew Porteus - Professor - Stanford University
Julie Tibbets - FDA Practice Chair - Goodwin Procter LLP
Learning Objectives
- Describe varying IIT program structures
- Describe potential challenges and considerations in designing an IIT program
This Module is Eligible for
ACRP CE Points, CCB Credits, CLE Credits, CME Credits, CNE Credits
ACRP CE Points
0.75